Vivos Therapeutics, Inc.
VVOS
$4.20
-$0.40-8.70%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.40M | 2.34M | 6.26M | 6.31M | 6.90M |
| Total Receivables | 1.63M | 718.00K | 430.00K | 454.00K | 395.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 695.00K | 547.00K | 783.00K | 634.00K | 554.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 6.73M | 3.61M | 7.47M | 7.40M | 7.85M |
|
|
|||||
| Total Current Assets | 6.73M | 3.61M | 7.47M | 7.40M | 7.85M |
| Net Property, Plant & Equipment | 8.37M | 4.26M | 4.38M | 4.45M | 4.48M |
| Long-term Investments | 8.45M | 2.84M | 2.84M | 2.84M | 2.84M |
| Goodwill | 8.45M | 2.84M | 2.84M | 2.84M | 2.84M |
| Total Other Intangibles | 2.23M | 358.00K | 370.00K | 383.00K | 395.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 255.00K | 215.00K | 216.00K | 276.00K | 276.00K |
| Total Assets | 26.03M | 11.28M | 15.28M | 15.35M | 15.84M |
|
|
|||||
| Total Accounts Payable | 1.76M | 1.21M | 1.10M | 1.08M | 2.03M |
| Total Accrued Expenses | 2.30M | 1.78M | 2.23M | 2.05M | 2.19M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 866.00K | 467.00K | 477.00K | 485.00K | 484.00K |
| Total Finance Division Other Current Liabilities | 1.50M | 1.24M | 1.17M | 1.51M | 1.95M |
| Total Other Current Liabilities | 1.50M | 1.24M | 1.17M | 1.51M | 1.95M |
| Total Current Liabilities | 6.43M | 4.70M | 4.98M | 5.13M | 6.64M |
|
|
|||||
| Total Current Liabilities | 6.43M | 4.70M | 4.98M | 5.13M | 6.64M |
| Long-Term Debt | 7.76M | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.96M | 932.00K | 1.04M | 1.16M | 1.28M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.31M | 1.24M | 1.32M | 1.40M | 1.57M |
| Total Liabilities | 21.45M | 6.88M | 7.33M | 7.68M | 9.50M |
|
|
|||||
| Common Stock & APIC | 117.65M | 112.46M | 112.14M | 109.03M | 105.09M |
| Retained Earnings | -113.06M | -108.05M | -104.19M | -101.36M | -98.74M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 4.58M | 4.41M | 7.95M | 7.67M | 6.35M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.58M | 4.41M | 7.95M | 7.67M | 6.35M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.58M | 4.41M | 7.95M | 7.67M | 6.35M |
|
|
|||||